This peptide is primarily used in the treatment of type 2 diabetes due to its ability to enhance insulin secretion in a glucose-dependent manner. It helps regulate blood sugar levels by stimulating insulin release from pancreatic beta cells while suppressing glucagon secretion, which reduces glucose production in the liver. Additionally, it slows gastric emptying, contributing to better post-meal glucose control and promoting a feeling of fullness, which can aid in weight management. It is also being explored for its potential benefits in improving cardiovascular health and protecting pancreatic beta cells. Its therapeutic applications make it a valuable component in diabetes management and related metabolic disorders.